Louisiana’s path to a medical marijuana program has been a tortuous and frustrating one.

A San Diego State University study found that after-hours cannabis use has no negatives effects on workplace performance but did find a negative correlation between those who used cannabis before and during work with task performance.

Field Trip adds a ketamine-assisted psychotherapy clinic to its operations.

Revive develops a new tannin-chitosan composite as a psychedelics delivery system.

PharmaDrug takes its first step to begin retail psychedelic sales in the legal market for psychedelic drugs in the Netherlands.

There is a magical moment in the pharmaceutical industry when a government approves a new treatment. For companies researching psilocybin, the psychoactive component in psychedelic mushrooms, that moment is now.

Six years after its first adult-use cannabis sale, Colorado set a monthly sales record in June totaling $158,102,628, according to state Department of Revenue Marijuana Enforcement Division Revenue outlined by the Denver Post. Last June, cannabis sales in the state reached about $122.4 million.

With the COVID-19 pandemic continuing to rage around the world, many are left wondering what, if any, is cannabis’ role in ameliorating the spread or possibly treating patients affected by the virus?

Four more Ohio cities will be voting on local measures to decriminalize marijuana this November, activists say.

Unlimited Science, a psychedelics non-profit R&D organization, is collaborating with Johns Hopkins.